{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/measles/how-up-to-date-is-this-topic/changes/","result":{"pageContext":{"chapter":{"id":"ef04938f-6cd8-5d2b-8031-e63619ffaae6","slug":"changes","fullItemName":"Changes","depth":2,"htmlHeader":"<!-- begin field 83c7614b-c90a-407f-b20b-fd148e956a88 --><h2>Changes</h2><!-- end field 83c7614b-c90a-407f-b20b-fd148e956a88 -->","summary":null,"htmlStringContent":"<!-- begin item 382a8c5b-fb4f-4634-a59a-e1262b6d189c --><!-- begin field cd1a6569-9d90-4892-9bf8-b5460a189c97 --><p><strong>March 2018</strong> — reviewed. A literature search was conducted in December 2017 to identify evidence-based guidelines, UK policy, systematic reviews, and key RCTs published since the last revision of this topic. No major changes to recommendations have been made, but there have been structural changes and a brief section on prevention (linking out to the CKS topic on Immunizations - childhood) has been added. Information on treatments not recommended has been removed.</p><!-- end field cd1a6569-9d90-4892-9bf8-b5460a189c97 --><!-- end item 382a8c5b-fb4f-4634-a59a-e1262b6d189c -->","topic":{"id":"0ec66249-42a4-5c0d-8a37-f2632ca7acde","topicId":"8b32d801-8035-4957-b21d-fdc0316b697d","topicName":"Measles","slug":"measles","lastRevised":"Last revised in March 2018","chapters":[{"id":"574596e7-391a-5ae2-bf0e-e7a3ac0db310","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"57c95110-4970-53c3-82ca-a0a02f782b1a","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"3968756f-72d2-5af8-a135-89adf3df1291","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"ef04938f-6cd8-5d2b-8031-e63619ffaae6","slug":"changes","fullItemName":"Changes"},{"id":"109f46c2-752c-5d34-a3a9-70f89ef6e6d8","slug":"update","fullItemName":"Update"}]},{"id":"0ac61cbb-f6a3-5cde-a49e-383cf998866c","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"af44849d-419b-5236-8667-1b06697011e9","slug":"goals","fullItemName":"Goals"},{"id":"8aa254cd-c0c4-5ad2-9778-896548b9ae3d","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"6e5a7bc2-88e4-5518-9a27-2c4cc8f96d43","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"e1e3d298-266c-53ca-a837-a43f7b51f000","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"e408b673-3cc9-556a-b3ad-7f2adc0c7e2f","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"4bbb33e5-786e-5140-803d-6c7d608ba7fd","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"25608b62-311c-5cfe-bf68-7953a8ee3737","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"da92a2f3-77ca-5048-8cae-2d7f1fbf552e","slug":"definition","fullItemName":"Definition"},{"id":"008ec2dd-b367-561a-8f55-c9d5ced49310","slug":"prevalence","fullItemName":"Prevalence"},{"id":"e8947faa-ab89-5369-a4ce-5d229aab4f40","slug":"complications","fullItemName":"Complications"},{"id":"c8086ee6-6b88-546f-9784-243317583284","slug":"prognosis","fullItemName":"Prognosis"},{"id":"f0a7fac1-bcd1-58ee-bd35-7c7cdd97c2b9","slug":"prevention","fullItemName":"Prevention"}]},{"id":"8a31ee21-9f32-5c22-955c-068539025090","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"258e5d5d-350e-51b5-b153-b71e658fa8b1","slug":"clinical-diagnosis","fullItemName":"Clinical diagnosis"},{"id":"60d5992e-b9ee-5ec0-8c37-2e09959645bf","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"42c95547-93f2-5eb8-a251-1331b9a2fae0","fullItemName":"Management","slug":"management","subChapters":[{"id":"daafe6b6-2230-5141-b9ba-d35b315dae91","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"652a2cc4-a89a-59a8-b1de-8e3927ccc932","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"1735c97d-c963-573a-b8b3-b03213e77a02","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"48a021d6-c031-58e0-9b01-8978137c72a8","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"c54e239c-eef4-5e71-9082-ef47671dd839","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"aaf0b0cb-35a7-52fb-96f9-e18ff97bd1b0","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"6248e49f-183f-5012-b8be-5fecfed55179","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"59da5ba6-9602-5e3c-9fa7-01b556316fbe","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"31dfda31-da84-5592-9695-d7dfc3dbdaee","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"3968756f-72d2-5af8-a135-89adf3df1291","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"a2325aee-e170-551a-a5f5-b0a31e889d9e","slug":"previous-changes","fullItemName":"Previous changes","depth":3,"htmlHeader":"<!-- begin field c1a8a67b-e9b0-4d04-bb99-24027a579952 --><h3>Previous changes</h3><!-- end field c1a8a67b-e9b0-4d04-bb99-24027a579952 -->","summary":null,"htmlStringContent":"<!-- begin item dec1dcce-0ae3-4301-a5a7-c385456675ca --><!-- begin field 59bd9b8c-7347-480d-8d55-5deabde510bb --><p><strong>August 2013</strong> — reviewed. A literature search was conducted in July 2013 to identify evidence-based guidelines, UK policy, systematic reviews, and key RCTs published since the last revision of this topic. No major changes to recommendations have been made.</p><p><strong>February 2013 </strong>— minor update. The 2013 QIPP options for local implementation have been added to this topic.</p><p><strong>October 2012 </strong>— minor update. The 2012 QIPP options for local implementation have been added to this topic.</p><p><strong>July 2011 </strong>— minor update. More recent prevalence data from the Health Protection Agency added. Issued in September 2011.</p><p><strong>July 2011 </strong>— minor update. More exact paracetamol dosing for children has been introduced by the Medicines and Healthcare products Regulatory Agency. Prescriptions have been updated to reflect the revised dosing. Issued in July 2011.</p><p><strong>May 2011 </strong>— minor update. The 2010/2011 QIPP options for local implementation have been added to this topic. Issued in June 2011.</p><p><strong>June 2010 </strong>— minor update to incorporate the latest recommendations from the Health Protection Agency. Issued in June 2010.</p><p><strong>July to November 2009 </strong>— this is a new CKS topic. The evidence-base has been reviewed in detail, and recommendations are clearly justified and transparently linked to the supporting evidence.</p><!-- end field 59bd9b8c-7347-480d-8d55-5deabde510bb --><!-- end item dec1dcce-0ae3-4301-a5a7-c385456675ca -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}